With a growing number of studies applying generative artificial intelligence (GAI) models for health purposes, reporting standards are being developed to guide authors in this space. We describe the currently available reporting guidelines that…
Continue Reading
Drug repurposing represents an attractive alternative to the costly and time-consuming process of new drug development, particularly for serious, widespread conditions with limited effective treatments, such as Alzheimer’s disease (AD). Emerging generative artificial intelligence…
Continue Reading
The following is a guest article by Archie Mayani, Chief Product Officer at GHX
Artificial Intelligence (AI) has been a game-changer in various industries, but its integration into healthcare has been a more gradual process….
